Skip to main content

Table 1 Clinicopathological characteristics of patients with RCC

From: A web-based prediction model for overall survival of elderly patients with early renal cell carcinoma: a population-based study

 

Total

N = 10,595

Training cohort

N = 7233

Validation cohort

N = 3024

p

Age

73.5 (6.73)

73.5 (6.69)

73.5 (6.83)

0.7

Race

   

0.4

 White

8300 (80.9%)

5847 (80.8%)

2453 (81.1%)

 

 Black

1132 (11.0%)

815 (11.3%)

317 (10.5%)

 

 Othera

825 (8.04%)

571 (7.89%)

254 (8.40%)

 

Sex

   

0.4

 Male

6406 (62.5%)

4498 (62.2%)

1908 (63.1%)

 

 Female

3851 (37.5%)

2735 (37.8%)

1116 (36.9%)

 

Marriage

   

0.5

 No

4026 (39.3%)

2856 (39.5%)

1170 (38.7%)

 

 Married

6231 (60.7%)

4377 (60.5%)

1854 (61.3%)

 

Year of diagnosis

   

0.06

 2010–2013

4815 (46.9%)

3352 (46.3%)

1463 (48.4%)

 

 2014–2017

5442 (53.1%)

3881 (53.7%)

1561 (51.6%)

 

Histologictype

   

0.5

 Clear cell

5539 (54.0%)

3932 (54.4%)

1607 (53.1%)

 

 Papillary

1658 (16.2%)

1173 (16.2%)

485 (16.0%)

 

 Chromophobe

578 (5.64%)

407 (5.63%)

171 (5.65%)

 

 Otherb

2482 (24.2%)

1721 (23.8%)

761 (25.2%)

 

Laterality

   

1

 Left

4996 (48.7%)

3523 (48.7%)

1473 (48.7%)

 

 Right

5261 (51.3%)

3710 (51.3%)

1551 (51.3%)

 

T stage

   

0.9

 T1a

6309 (61.5%)

4452 (61.6%)

1857 (61.4%)

 

 T1b

2907 (28.3%)

2045 (28.3%)

862 (28.5%)

 

 T2a

764 (7.45%)

538 (7.44%)

226 (7.47%)

 

 T2b

277 (2.70%)

198 (2.74%)

79 (2.61%)

 

Grade

   

0.7

 I

993 (9.68%)

715 (9.89%)

278 (9.19%)

 

 II

3923 (38.2%)

2782 (38.5%)

1141 (37.7%)

 

 III

1846 (18.0%)

1293 (17.9%)

553 (18.3%)

 

 IV

177 (1.73%)

123 (1.70%)

54 (1.79%)

 

 Unknown

3318 (32.3%)

2320 (32.1%)

998 (33.0%)

 

Surgery

   

0.044

 No

2040 (19.9%)

1387 (19.2%)

653 (21.6%)

 

 Local excisionc

1446 (14.1%)

1035 (14.3%)

411 (13.6%)

 

 Partial Nephrectomy

2973 (29.0%)

2119 (29.3%)

854 (28.2%)

 

 Radical Nephrectomy

3798 (37.0%)

2692 (37.2%)

1106 (36.6%)

 

Chemotherapy

   

0.9

 No/unknown

10,182 (99.3%)

7179 (99.3%)

3003 (99.3%)

 

 Yes

75 (0.73%)

54 (0.75%)

21 (0.69%)

 

Radiation

   

0.9

 No/unknown

10,223 (99.7%)

7210 (99.7%)

3013 (99.6%)

 

 Yes

34 (0.33%)

23 (0.32%)

11 (0.36%)

 

Total number of tumors

1.62 (0.84)

1.62 (0.84)

1.61 (0.82)

0.7

Tumor size

41.1 (27.2)

41.1 (26.9)

41.0 (28.1)

0.9

Survival months

47.4 (28.1)

47.3 (28.2)

47.8 (27.9)

0.4

Cancer-specific survival

   

0.8

 Dead

786 (7.66%)

558 (7.71%)

228 (7.54%)

 

 Alive

9471 (92.3%)

6675 (92.3%)

2796 (92.5%)

 

Overall survival

   

0.5

 Dead

2623 (25.6%)

1836 (25.4%)

787 (26.0%)

 

 Alive

7634 (74.4%)

5397 (74.6%)

2237 (74.0%)

 
  1. aOther includes Asian/Pacific Islander, American Indian/Alaskan Native;
  2. bOthers includes the pathological type of RCC is not known
  3. cLocal excision includes cryosurgery, thermal ablation, laser excision
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us